• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Japan studying giving third COVID-19 shots next year

firstwordpharmaAugust 09, 2021

Tag: COVID-19 , Vaccine , Moderna

Japan has begun a study on whether it should administer third doses of COVID-19 vaccines next year, as reported The Japan Times.

The government will proceed with the study while trying to secure the supply of at least 200 million doses next year, officials said.

Japan studying giving third COVID-19 shots next year

Taro Kono, the minister in charge of vaccination efforts, has said that Japan "will likely administer next year" third doses of the COVID-19 vaccine.

In July, the government struck a contract to receive an additional 50 million doses of Moderna's vaccine from the beginning of 2022, and discussions are under way to secure 150 million doses of the vaccine developed by Novavax starting in early 2022.


Previous:FDA to allow export of certain lots of AstraZeneca COVID-19 vaccine made at Baltimore plant

Next:JCVI ‘largely opposed’ to Covid vaccination for children under 16

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Japan studying giving third COVID-19 shots next year | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Vi Polysaccharide Typhoid Vaccine

Vi Polysaccharide Typhoid Vaccine
Poultry Vaccine Series 2

Poultry Vaccine Series 2
OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral

OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral
B11 100ml amber plastic vaccine bottle

B11 100ml amber plastic vaccine bottle
Inactivated Hepatitis A Vaccine

Inactivated Hepatitis A Vaccine
Rabies Vaccine(Human Diploid Cell)

Rabies Vaccine(Human Diploid Cell)
IPV(Inactivated Poliovirus Vaccine)

IPV(Inactivated Poliovirus Vaccine)
B28 pp 100ml autoclaved vaccine bottle

B28 pp 100ml autoclaved vaccine bottle
Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live

Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live
Animal Vaccine Filling Line

Animal Vaccine Filling Line

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service